| Date Filed | Type | Description |
| 10/15/2018 |
GN
| Matinas BioPharma Appoints Global Pharmaceutical Drug Development Industry Leader Theresa Matkovits, Ph.D., Chief Development Officer; Further Expands Manufacturing and Clinical Development Team |
| 09/25/2018 |
GN
| Consolidated Research: 2018 Summary Expectations for Community Health, Aradigm, Avnet, Sanchez Energy, Black Stone Minerals, and Navient — Fundamental Analysis, Key Performance Indications |
| 04/16/2018 |
GN
| New Research Coverage Highlights Aradigm, Ultra Petroleum, TRI Pointe Group, Finisar, Tesla, and The Progressive — Consolidated Revenues, Company Growth, and Expectations for 2018 |
| 03/23/2018 |
BW
| Aradigm Announces Fourth Quarter 2017 and Full Year Financial Results |
| 03/07/2018 |
GN
| DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018 |
| 02/15/2018 |
GN
| The Klein Law Firm Reminds Shareholders of Aradigm Corporation of a Class Action and a Lead Plaintiff Deadline of March 12, 2018 (ARDM) |
| 02/13/2018 |
GN
| ARDM INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Aradigm Corporation and a Lead Plaintiff Deadline of March 12, 2018 |
| 02/12/2018 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aradigm Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2018 – ARDM |
| 02/02/2018 |
GN
| ARADIGM ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Aradigm Corporation To Contact The Firm |
| 01/29/2018 |
GN
| The Klein Law Firm Announces a Class Action Filed on Behalf of Aradigm Corporation Shareholders and a Lead Plaintiff Deadline of March 12, 2018 (ARDM) |
| 01/27/2018 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aradigm Corporation of Class Action Lawsuit and Upcoming Deadline – ARDM |
| 01/25/2018 |
GN
| ARDM SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Aradigm Corporation and a Lead Plaintiff Deadline of March 12, 2018 |
| 01/22/2018 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Aradigm Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2018 – ARDM |
| 01/16/2018 |
GN
| SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Aradigm Corporation (Nasdaq: ARDM) To Contact Brower Piven Before The Lead Plaintiff Deadline |
| 01/16/2018 |
GN
| SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018 |
| 01/12/2018 |
GN
| Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Aradigm Corporation (ARDM) |
| 01/11/2018 |
GN
| Aradigm Reports Results of FDA Advisory Committee Meeting on Linhaliq |
| 11/27/2017 |
GN
| Analysis: Positioning to Benefit within Aradigm, General Motors, AT&T, Denbury Resources, Novavax, and Immunomedics — Research Highlights Growth, Revenue, and Consolidated Results |
| 11/02/2017 |
BW
| Aradigm Announces Third Quarter 2017 Financial Results |
| 09/22/2017 |
BW
| Aradigm to Present at the Ladenburg Thalmann 2017 Healthcare Conference on September 26 |
| 09/15/2017 |
BW
| Aradigm to Host KOL Call on Infection Management in Non-Cystic Fibrosis Bronchiectasis Patients |
| 08/10/2017 |
BW
| Aradigm Announces Second Quarter 2017 Financial Results |
| 05/15/2017 |
BW
| Aradigm Announces First Quarter 2017 Financial Results |
| 03/28/2017 |
BW
| Aradigm Announces Fourth Quarter 2016 and Full Year Financial Results |
| 07/06/2011 |
BW
| Aradigm Announces Private Placement for $4.75 Million |
| 05/12/2011 |
BW
| Aradigm Announces First Quarter 2011 Financial Results |